The pooled HR for OS showed that decreased RUNX3 expression was associated with worse survival in esophageal cancer as shown in Figure 5 (HR = 4.31, 95% CI = 2.57–7.37, P<0.00001). The gene discussed is RUNX3; the disease is esophageal cancer.